EP2854858

RISPERIDONE IMPLANT FORMULATION

  • Status:
    EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á Íslandi
  • EP appl. date:
    31.5.2013
  • EP published:
    10.12.2025
  • EP application number:
    13726003.0
  • Max expiry date:
    30.5.2033
  • Expiry date:
    30.5.2026
  • Title in English:
    RISPERIDONE IMPLANT FORMULATION
  • Language of the patent:
    English

Timeline

Today
31.5.2013EP application
10.12.2025EP Publication
30.5.2026Expires

Owner

  • Name:
    Laboratorios Farmacéuticos Rovi, S.A.
  • Address:
    C/ Julián Camarillo 35, 28037 Madrid, ES

Inventor

  • Name:
    GUTIERRO ADURIZ, Ibon
  • Address:
    E-28037 Madrid, ES
  • Name:
    FRANCO RODRÍGUEZ, Guillermo
  • Address:
    E-28037 Madrid, ES

Priority

  • Number:
    12170362
  • Date:
    31.5.2012
  • Country:
    EP

Classification

  • Categories:
    A61K 47/34

Upload documents